Alexander Gorka

Alexander Gorka

(416) 862-4857
(416) 862-6666
100 King St W, Suite 6200, 1 First Cdn Pl, PO Box 50, Toronto, ON
Year called to bar: 2010 (ON)
Alex is Co-Chair of Osler's Mergers and Acquisitions Group. He regularly acts on Canada’s most high profile and complex transactions, delivering practical advice to private and public companies, private equity sponsors, and special committees on a diverse range of strategic mandates across various industries. His private equity deal experience includes acting for Blackstone, iCON Infrastructure, Sculptor, Paine Schwartz, Inspirit, Platinum Equity, Sterling Partners and Penfund. He has advised on numerous REIT transactions including on behalf of Dream, Koch Real Estate Investments, SmartCentres, KingSett and Ventas. Alex has completed two secondments to the Office of Mergers and Acquisitions of the Ontario Securities Commission, first in 2012 where he helped develop a new rule on shareholder rights plans as well as proposed amendments to the early warning regime, and again in 2017 where he was one of the primary drafters of the CSA Staff Notice on conflict of interest transactions (Multilateral CSA Staff Notice 61-302 Staff Review and Commentary on Multilateral Instrument 61-101). Alex is an adjunct professor at the University of Toronto Faculty of Law, where he teaches Mergers and Acquisitions in the Global Professional Master of Laws (GPLLM) program. 
Alexander Gorka is a featured Leading Lawyer in:
Canadian Legal Lexpert Directory
Repeatedly Recommended
Read more about Alexander Gorka in ...
Acquisition set to create comprehensive radiology and oncology solutions for patients in U.S.
On April 29, 2015, Mitel Networks Corporation, a global leader in business communications, acquired Mavenir Systems, Inc., creating a global leader in converged IP communications. Mitel expects to expand its total addressable market by approximately US$14 billion by 2018, positioning the company to capitalize on increasing demand for 4G LTE services.
Valeant Pharmaceuticals International, Inc. (Valeant) acquired Salix Pharmaceuticals, Ltd. (Salix) for US$173.00 per share in cash, or a total enterprise value of approximately US$15.8 billion. The transaction closed on April 1, 2015. To partially finance the acquisition, Valeant completed equity and bond offerings, which closed on March 27, 2015. In its equity offer, Valeant issued 7,286,482 shares at a price of US$199.00 per share, for aggregate gross proceeds of approximately US$1.45 billion.
First Quantum Minerals Ltd. (“First Quantum” or the “Company”) and its wholly-owned subsidiary FQM (Akubra) Inc. (together, the “Offeror”) announced that, as of 5:00 p.m. EST on April 1, 2013, a total of 65,206,044 common shares of Inmet Mining Corporation (“Inmet”), representing 92.74 per cent of the outstanding Inmet shares (on a fully diluted basis), had been validly tendered to the Offeror's offer (the “Offer”) to acquire all of the outstanding shares of Inmet.